相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
Dove 医学期刊 APC 折后约 1.95w,中国大陆作者专享AJE 润色 84 折,送京东卡等福利,优惠码 DXYAJE五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- 规格:
10 mM * 1 mL/5 mg/10 mg/25 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1045.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥950.0 |
| 规格: | 10 mg | 产品价格: | ¥1600.0 |
| 规格: | 25 mg | 产品价格: | ¥3500.0 |
| 规格: | 50 mg | 产品价格: | ¥5950.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
PKUMDL-WQ-2201
CAS No. : 592474-91-4
MCE 国际站:PKUMDL-WQ-2201
产品活性:PKUMDL-WQ-2201 是一种 PHGDH 非 NAD+ 竞争变构抑制剂 (IC50=35.7 μM)。PKUMDL-WQ-2201 对 PHGDH 突变体的 IC50 分别为 69 μM (T59A) 和300 μM (T56AK57A)。PKUMDL-WQ-2201 抑制癌细胞中丝氨酸的从头合成,并减少肿瘤生长。
研究领域:Metabolic Enzyme/Protease
作用靶点:Phosphoglycerate Dehydrogenase (PHGDH)
In Vitro: PKUMDL-WQ-2201 (10 nM-100 μM; 3 d) shows good selectivity for PHGDH-amplified breast cancer cell lines, inhibits cell viability with EC50s of 7.7 μM (MDA-MB-468) and 10.8 μM (HCC70), respectively.
In Vivo: PKUMDL-WQ-2201 (5-20 mg/kg; i.p.; once daily for 30 d) exhibits substantial inhibitory effects on MDA-MB-468 xenografts compared with vehicle-treated mice, without affecting the tumor growth.
相关产品:Bioactive Compound Library Plus | Metabolism/Protease Compound Library | Anti-Cancer Compound Library | Anti-Breast Cancer Compound Library | Anti-Cancer Metabolism Compound Library | Cysteine Targeted Covalent Library | NCT-503 | CBR-5884 | BI-4916 | NCT-502 | PHGDH-inactive | PKUMDL-WQ-2101 | PHGDH-IN-3 | PHGDH-IN-2
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料


















